CMPS: the cash flow

MyFinsight

For the year ending 2025-12-31, CMPS had -$15,483K decrease in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Loss from operations	-179,037
Fair value change of warrant liabilities	122,561
Benefit from r&d tax credit	-3,747
Interest income	7,182
Interest expense	4,517
Foreign exchange gains (losses)	3,471
Other income	1,380
Income tax benefit (expense)	-2,473
Net loss	-287,862
Depreciation	216
Non-cash interest	1,468
Non-cash gain (loss) on foreign currency remeasurement	1,152
Non-cash share-based compensation	13,590
Non-cash lease expenses	2,410
Transaction costs allocated to warrants	5,778
Fair value change of warrant liabilities	122,561
Prepaid expenses and other current assets	3,238
Deferred and prepaid tax assets	-23
Other assets	4,711
Operating lease liabilities	-2,452
Accounts payable	2,034
Accrued expenses and other liabilities	-5,905
Net cash used in operating activities	-157,240
Proceeds from issuance of ordinary shares and pre-funded warrants, net of issuance costs	140,357
Proceeds from the exercise of warrants	0
Proceeds from the vesting of restricted share units	1
Payments of withholding tax on stock award	0
Proceeds from the issuance of shares under the employee share purchase plan	319
Proceeds from exercise of options	35
Net cash provided by financing activities	140,712
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,045
Net (decrease)/increase in cash, cash equivalents and restricted cash	-15,483
Cash, cash equivalents and restricted cash, beginning of the period	165,470
Cash, cash equivalents and restricted cash, end of the period	149,987

Unit: Thousand (K) dollars (except for numbers of shares and EPS).